share_log

BridgeBio Pharma(BBIO.US) Director Sells US$73,500 in Common Stocks

moomoo News ·  Dec 5, 2023 16:38

$BridgeBio Pharma (BBIO.US)$ Director Scott Randal W. sold 2,500 shares of Common Stocks on Dec 1, 2023 at an average price of $29.4 for a total value of $73,500.

1701812313785784850.png

What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment